…
CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Cleanspace Holdings designs and sells powered air‑purifying respirators, filters and replacement consumables for industrial, healthcare and emergency-service users across multiple markets. Long-term growth may be supported by stricter workplace-safety regulations, recurring consumables revenue and expansion into larger international markets. The company's specialized respiratory-technology platform and aftermarket sales appear positioned to provide durable revenue streams.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 0.46M | -1.03M | -4.59M | -11.83M | -15.28M |
| Net income | -1.25M | -0.48M | -3.13M | -8.13M | -11.28M |
| Selling general administrative | - | 3.59M | 12.05M | 18.45M | 17.14M |
| Selling and marketing expenses | - | 1.02M | 1.56M | - | 4.05M |
| Gross profit | 4.07M | 14.78M | 11.36M | 8.41M | 9.75M |
| Reconciled depreciation | - | 0.92M | 0.96M | 1.04M | 1.02M |
| Ebit | -2.37M | -1.28M | -4.45M | -11.83M | -15.13M |
| Ebitda | -1.60M | -0.82M | -3.49M | -10.63M | -14.11M |
| Depreciation and amortization | 0.77M | 0.46M | 0.96M | - | 1.02M |
| Operating income | -2.37M | -1.28M | -4.74M | -11.82M | -15.13M |
| Other operating expenses | 22.19M | 21.05M | 20.54M | - | 28.48M |
| Interest expense | 0.15M | 0.09M | 0.14M | 0.16M | 0.16M |
| Tax provision | - | -0.55M | -1.46M | -3.69M | -4.00M |
| Interest income | - | 0.34M | 0.37M | 0.01M | 0.06M |
| Net interest income | - | 0.25M | 0.22M | -0.01M | -0.21M |
| Income tax expense | 1.71M | 0.55M | -1.46M | -3.69M | -4.00M |
| Total revenue | 19.82M | 19.76M | 15.72M | 12.09M | 13.36M |
| Total operating expenses | 6.44M | 16.06M | 16.17M | - | 24.87M |
| Cost of revenue | 15.75M | 4.99M | 4.36M | 3.69M | 3.61M |
| Total other income expense net | 2.82M | 0.25M | 0.15M | 0.01M | 0.05M |
| Net income from continuing ops | - | -0.48M | -3.13M | -8.13M | -11.28M |
| Net income applicable to common shares | - | -0.48M | -3.13M | -8.13M | -11.28M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 23.46M | 27.57M | 26.05M | 28.98M | 38.36M |
| Other current assets | 0.33M | - | 0.41M | 1.24M | 3.48M |
| Total liab | 4.96M | 8.41M | 6.95M | 7.02M | 8.60M |
| Total stockholder equity | 18.50M | 19.16M | 19.10M | 21.96M | 29.75M |
| Other current liab | 2.24M | - | 2.57M | 1.55M | 3.41M |
| Common stock | 34.26M | - | 33.55M | 33.44M | 33.43M |
| Capital stock | - | 33.87M | - | 33.44M | 33.43M |
| Retained earnings | -16.58M | -15.49M | -15.17M | -12.23M | -4.16M |
| Other liab | - | - | - | 0.36M | 0.42M |
| Other assets | - | - | 0.00M | 6.31M | 0.90M |
| Cash | 1.71M | 2.52M | 2.75M | 3.12M | 8.22M |
| Total current liabilities | 3.29M | 3.62M | 3.76M | 3.30M | 7.02M |
| Current deferred revenue | 0.00M | - | 0.04M | - | - |
| Net debt | -0.26M | 0.31M | 0.70M | - | -4.09M |
| Short term debt | 0.28M | - | 0.53M | 0.00M | 2.97M |
| Short long term debt | - | - | - | 0.15M | 2.53M |
| Short long term debt total | 1.45M | - | 3.45M | - | 4.13M |
| Other stockholder equity | - | - | - | 0.75M | 0.48M |
| Property plant equipment | - | - | - | 2.40M | 3.44M |
| Total current assets | 17.47M | 18.38M | 17.64M | 20.26M | 33.99M |
| Net tangible assets | - | - | - | 21.95M | 29.73M |
| Short term investments | 8.37M | 7.95M | 7.02M | 9.04M | 16.08M |
| Net receivables | 4.83M | 3.52M | 4.59M | 3.32M | 2.47M |
| Long term debt | - | 2.83M | - | 2.68M | - |
| Inventory | 2.23M | 2.25M | 2.87M | 2.99M | 3.74M |
| Accounts payable | 0.77M | 0.71M | 0.62M | 0.26M | 0.64M |
| Accumulated other comprehensive income | 0.82M | - | 0.73M | - | 0.48M |
| Non currrent assets other | - | - | -0.00M | - | - |
| Non current assets total | 5.99M | 9.19M | 8.41M | 8.72M | 4.36M |
| Capital lease obligations | - | 1.70M | - | 1.16M | 1.60M |
| Long term debt total | - | - | - | 3.36M | 1.16M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.78M | 2.00M | 7.04M | -0.04M |
| Change to liabilities | - | - | - | -4.02M | 0.48M |
| Total cashflows from investing activities | -0.62M | -0.78M | 2.00M | 7.06M | -0.63M |
| Net borrowings | - | - | -0.15M | -0.21M | -0.36M |
| Total cash from financing activities | -0.25M | -0.56M | -0.64M | -0.21M | -0.36M |
| Change to operating activities | - | - | - | 0.07M | -0.12M |
| Net income | -1.25M | -0.48M | -3.13M | -8.13M | -11.28M |
| Change in cash | -0.81M | -0.23M | -0.37M | -5.11M | -13.98M |
| Begin period cash flow | 2.52M | 2.75M | 3.12M | 8.22M | 22.21M |
| End period cash flow | 1.71M | 2.52M | 2.75M | 3.12M | 8.22M |
| Total cash from operating activities | 0.07M | 1.11M | -1.73M | -11.96M | -13.00M |
| Depreciation | 0.77M | 0.92M | 0.96M | 1.02M | 1.00M |
| Other cashflows from investing activities | - | 0.26M | 2.03M | 7.07M | -0.02M |
| Change to inventory | 0.03M | 0.61M | 0.12M | 0.75M | 0.72M |
| Change to account receivables | -0.00M | -0.69M | -0.02M | -0.95M | -0.01M |
| Sale purchase of stock | - | - | - | - | 0.00M |
| Other cashflows from financing activities | -0.25M | -0.03M | -0.48M | - | -0.63M |
| Change to netincome | - | - | - | 0.41M | 0.54M |
| Capital expenditures | 0.21M | 0.10M | 0.03M | 0.01M | 0.61M |
| Change in working capital | 2.79M | -0.05M | 0.17M | 0.08M | -0.10M |
| Stock based compensation | - | 0.41M | 0.27M | - | - |
| Other non cash items | -2.24M | 0.30M | 0.00M | - | - |
| Free cash flow | -0.14M | 1.01M | -1.76M | -11.97M | -0.61M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CSX Cleanspace Holdings Ltd |
-0.04 7.22% |
0.45 | - | - | 2.01 | 2.02 | 1.45 | 23.38 |
| COH Cochlear Ltd |
1.03 0.67% |
155.47 | 68.64 | 27.40 | 4.30 | 5.34 | 3.97 | 28.09 |
| IMR Imricor Medical Systems Inc |
-0.03 2.29% |
1.28 | - | - | 36401.21 | 17.45 | 4019.33 | -2.60 |
| AVR Anteris Technologies Global Corp |
-0.36 4.21% |
8.20 | - | - | 356.02 | 2.19 | 130.34 | -5.20 |
| AVH Avita Medical Inc |
-0.08 1.73% |
4.55 | - | 9.97 | 9.59 | 7.17 | 6.76 | 15.37 |
CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.
39 Herbert Street, St Leonards, NSW, Australia, 2065
61 2 8436 4000
53
| Name | Title | Year Born |
|---|---|---|
| Dr. Alexandra Birrell | CEO & Exec. Director | NA |
| Ms. Elizabeth Harvey | CFO & Joint Company Sec. | NA |
| Mr. Dan Kao | Director of Operations & Exec. Director | NA |
| Mr. Alex Virr | Chief Technology Officer | NA |
| Mr. Jon Imms | Global Sales Director | NA |
| Ms. Elissa Hansen | Joint Company Sec. | NA |
| Mr. Graham A. McLean CPA, CIMA | CEO & Director | 1965 |
| Mr. Dan Kao | Director of Innovation & Operations and Executive Director | NA |
| Ms. Bree Greeff | Interim Chief Financial Officer | NA |
| Mr. Graham A. McLean CPA, CIMA | CEO & Director | 1965 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.